Longview Partners Portfolio holdings
Longview Partners is a specialist global equity manager that holds a concentrated portfolio of world stocks, using the same philosophy since it started in 2001. It looks for high-quality businesses that can build value steadily over time, wants a margin of safety on price, and relies on picking individual stocks rather than steering the overall portfolio. Its clients are institutions, and Northill Capital is its majority shareholder.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$577M |
| 2 |
State Street
STT
|
+$274M |
| 3 |
W.W. Grainger
GWW
|
+$174M |
| 4 |
Parker-Hannifin
PH
|
+$57.4M |
| 5 |
Progressive
PGR
|
+$43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$308M |
| 2 |
Fiserv Inc
FISV
|
+$71.9M |
| 3 |
Accenture
ACN
|
+$16.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.21% |
| 2 | Financials | 27.88% |
| 3 | Technology | 18.7% |
| 4 | Industrials | 15.03% |
| 5 | Consumer Discretionary | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Aon
AON
$68.2B
| $891M | 5.14% |
6,700,077
+114,690
| +2% | +$14.5M |
2013 Q2
16 quarters
|
|
|
2
Progressive
PGR
$134B
| $862M | 4.97% |
19,547,018
+1,035,246
| +6% | +$43M |
2015 Q1
9 quarters
|
|
3
Aptiv
APTV
$9.12B
| $857M | 4.94% |
9,772,666
+300,071
| +3% | +$25M |
2013 Q2
16 quarters
|
|
4
Bank of New York Mellon
BNY
$99B
| $843M | 4.86% |
16,519,184
+726,898
| +5% | +$34.8M |
2013 Q2
16 quarters
|
|
5
UnitedHealth
UNH
$365B
| $836M | 4.82% |
4,510,545
+151,208
| +3% | +$26.5M |
2014 Q1
13 quarters
|
|
|
6
Parker-Hannifin
PH
$113B
| $821M | 4.73% |
5,134,958
+362,076
| +8% | +$57.4M |
2015 Q2
8 quarters
|
|
7
Zimmer Biomet
ZBH
$18B
| $819M | 4.72% |
6,569,042
+277,259
| +4% | +$32.9M |
2015 Q3
7 quarters
|
|
8
Oracle
ORCL
$396B
| $815M | 4.7% |
16,247,371
+716,802
| +5% | +$32.7M |
2013 Q2
16 quarters
|
|
9
Fidelity National Information Services
FIS
$19.9B
| $812M | 4.68% |
9,504,642
+428,628
| +5% | +$35.9M |
2013 Q2
16 quarters
|
|
10
HCA Healthcare
HCA
$102B
| $792M | 4.57% |
9,081,454
+414,598
| +5% | +$35.1M |
2013 Q3
15 quarters
|
|
11
IQVIA
IQV
$44.1B
| $780M | 4.5% |
8,711,447
+505,526
| +6% | +$42.7M |
2016 Q4
2 quarters
|
|
12
Willis Towers Watson
WTW
$29.9B
| $774M | 4.46% |
5,322,466
+256,179
| +5% | +$35.8M |
2016 Q2
4 quarters
|
|
13
Emerson Electric
EMR
$92B
| $753M | 4.34% |
12,624,050
+526,712
| +4% | +$31.2M |
2015 Q1
9 quarters
|
|
14
Thermo Fisher Scientific
TMO
$258B
| $742M | 4.28% |
4,251,131
+84,180
| +2% | +$14.1M |
2015 Q3
7 quarters
|
|
15
Wells Fargo
WFC
$250B
| $695M | 4.01% |
12,544,667
+636,994
| +5% | +$34.1M |
2013 Q2
16 quarters
|
|
|
16
State Street
STT
$46.2B
| $679M | 3.92% |
7,569,482
+3,290,082
| +77% | +$274M |
2017 Q1
1 quarter
|
|
|
17
W.W. Grainger
GWW
$64B
| $678M | 3.91% |
3,755,706
+923,948
| +33% | +$174M |
2015 Q4
6 quarters
|
|
|
18
Accenture
ACN
$158B
| $637M | 3.68% |
5,153,945
-135,366
| -3% | -$16.5M |
2013 Q2
16 quarters
|
|
19
Pfizer
PFE
$174B
| $620M | 3.58% |
19,465,875
+1,253,268
| +7% | +$39.5M |
2013 Q2
16 quarters
|
|
|
20
Dollar General
DG
$29.2B
| $578M | 3.33% |
+8,011,492
| New | +$577M |
2017 Q2
0 quarters
|
|
|
21
Fiserv Inc
FISV
$26.6B
| $535M | 3.08% |
8,742,796
-1,188,480
| -12% | -$71.9M |
2013 Q2
16 quarters
|
|
|
TMX
22
DELISTED
Terminix Global Holdings, Inc.
TMX
| $356M | 2.05% |
13,546,286
+694,140
| +5% | +$18.2M |
2016 Q2
4 quarters
|
|
23
Omnicom Group
OMC
$22.3B
| $332M | 1.91% |
4,000,490
+213,081
| +6% | +$17.8M |
2014 Q1
13 quarters
|
|
24
Pediatrix Medical
MD
$2.33B
| $303M | 1.75% |
5,023,476
+467,845
| +10% | +$27.7M |
2016 Q4
2 quarters
|
|
25
Arrow Electronics
ARW
$10.6B
| $219M | 1.26% |
2,792,564
+116,338
| +4% | +$8.69M |
2013 Q2
16 quarters
|
|
Similar funds
Longview Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Longview Partners held 28 positions worth $17.3B, up 13% from $15.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Longview Partners deployed $1.27B of net new capital in Q2 2017, opening 1 new position and adding to 24 existing holdings. Its largest new stake was Dollar General: 8,011,492 shares worth $578M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was TE Connectivity, an estimated $308M trimmed.
- Longview Partners's largest Q2 2017 buy was Dollar General: 8,011,492 shares worth $578M.
- Longview Partners added most to State Street in Q2 2017, an estimated $274M increase.
- Longview Partners's biggest Q2 2017 reduction was TE Connectivity, cutting an estimated $308M.
- Longview Partners's ten largest holdings make up 48% of its $17.3B portfolio in Q2 2017.
- Longview Partners opened 1 new position and closed 0 in Q2 2017.
- Longview Partners's portfolio value rose 13% quarter-over-quarter to $17.3B.
Based on Longview Partners's 13F filing for Q2 2017, filed 26 Jul 2017.